{
  "id": "LAB-GLUC-HYPO-003",
  "name": "Hipoglicemia Leve",
  "category": "LAB",
  "subcategory": "GLUCOSE",
  "description": "Alerta para hipoglicemia leve 54-69 mg/dL com necessidade de ajuste terapêutico",
  "version": "1.0.0",
  "created": "2026-02-06",
  "updated": "2026-02-06",
  "author": "Clinical Alert Specialist",
  "status": "active",
  "priority": "MEDIUM",
  "clinicalRationale": "Hipoglicemia leve (54-69 mg/dL) é clinicamente importante segundo ADA 2024, ativando respostas contra-regulatórias e indicando necessidade de revisão do esquema terapêutico. Episódios recorrentes aumentam risco de hipoglicemia severa e unawareness.",
  "inputVariables": [
    {
      "name": "glicemia",
      "type": "number",
      "unit": "mg/dL",
      "description": "Glicemia sérica",
      "required": true,
      "normalRange": "70-100 mg/dL (fasting)"
    }
  ],
  "outputVariables": [
    {
      "name": "nivelAlerta",
      "type": "string",
      "values": ["Atencao", "OK"]
    },
    {
      "name": "urgencia",
      "type": "string",
      "values": ["URGENTE", "NORMAL"]
    },
    {
      "name": "classificacao",
      "type": "string"
    },
    {
      "name": "tendencia",
      "type": "string"
    },
    {
      "name": "acaoRequerida",
      "type": "string"
    },
    {
      "name": "justificativaCientifica",
      "type": "string"
    }
  ],
  "references": [
    "ADA Standards of Medical Care in Diabetes 2024",
    "Seaquist ER, et al. Hypoglycemia and diabetes: a report of a workgroup of the ADA and Endocrine Society. Diabetes Care 2013",
    "International Hypoglycaemia Study Group: Glucose concentrations of less than 3.0 mmol/L (54 mg/dL) should be reported in clinical trials"
  ],
  "tags": ["medium-priority", "glucose", "hypoglycemia", "mild", "therapy-adjustment", "counter-regulation"]
}
